Unnamed Pharmaceuticals: Legal opinion from Zhejiang Tianzui (Shenzhen) Law Firm on the awarding of Shandong Weiming Biomedical Co., Ltd.\'s 2023 stock option incentive plan

SZSI · May 30, 2023 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.